Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Mechanism of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy After Myocarditis

NCT05961202 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT05961202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05961202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Mechanism of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy After Myocarditis
Lead sponsor
Tongji Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
November 1, 2021
Completion date
November 1, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory cardiomyopathy, myocarditis